Analysts’ Updated EPS Estimates for October 15th (ACI, ARWR, BAC, BBOX, BEAM, BHF, BLND, BLTE, BRK, BWA)

Analysts’ updated eps estimates for Thursday, October 15th:

Albertsons Companies (NYSE:ACI) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. They currently have $14.00 target price on the stock.

Albertsons Companies (NYSE:ACI) was downgraded by analysts at The Goldman Sachs Group, Inc. from a buy rating to a neutral rating. The Goldman Sachs Group, Inc. currently has $13.00 price target on the stock.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $120.00 target price on the stock.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its buy rating reissued by analysts at Chardan Capital. The firm currently has a $115.00 price target on the stock.

Bank of America (NYSE:BAC) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. The firm currently has $62.00 price target on the stock.

Tritax Big Box REIT (LON:BBOX) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 201 target price on the stock.

Beam Therapeutics (NASDAQ:BEAM) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $80.00 price target on the stock.

Brighthouse Financial (NASDAQ:BHF) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating. JPMorgan Chase & Co. currently has $55.00 price target on the stock, down from their previous price target of $63.00.

British Land (LON:BLND) had its underperform rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 331 price target on the stock.

Belite Bio (NASDAQ:BLTE) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $245.00 target price on the stock.

Brooks Macdonald Group (LON:BRK) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 1,780 target price on the stock.

BorgWarner (NYSE:BWA) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. They currently have $85.00 price target on the stock.

Big Yellow Group (LON:BYG) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a GBX 898 price target on the stock.

Bytes Technology Group (LON:BYIT) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 520 target price on the stock.

Central Asia Metals (LON:CAML) had its hold rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 160 price target on the stock.

Chemring Group (LON:CHG) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a GBX 658 target price on the stock.

Clarkson (LON:CKN) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 5,550 target price on the stock.

Core Scientific (NASDAQ:CORZ) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $38.00 price target on the stock.

Core Scientific (NASDAQ:CORZ) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $36.00 price target on the stock.

Credo Technology Group (NASDAQ:CRDO) had its neutral rating reissued by analysts at Rosenblatt Securities. They currently have a $235.00 price target on the stock.

Diebold Nixdorf (NYSE:DBD) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $100.00 price target on the stock.

American Axle & Manufacturing (NYSE:DCH) was downgraded by analysts at Bank of America Corporation from a buy rating to an underperform rating. They currently have $5.00 price target on the stock.

Deckers Outdoor (NYSE:DECK) had its market perform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $105.00 target price on the stock.

Derwent London (LON:DLN) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 1,655 price target on the stock.

Dunelm Group (LON:DNLM) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a GBX 1,030 price target on the stock.

Dianthus Therapeutics (NASDAQ:DNTH) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $158.00 price target on the stock.

discoverIE Group (LON:DSCV) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 685 price target on the stock.

Establishment Labs (NASDAQ:ESTA) had its buy rating reaffirmed by analysts at TD Cowen. They currently have a $117.00 price target on the stock.

Frontier Developments (LON:FDEV) had its buy rating reaffirmed by analysts at Shore Capital Group Ltd. The firm currently has a GBX 650 price target on the stock.

GlobalFoundries (NASDAQ:GFS) had its buy rating reaffirmed by analysts at TD Cowen. TD Cowen currently has a $75.00 target price on the stock.

GlobalFoundries (NASDAQ:GFS) had its neutral rating reaffirmed by analysts at Wedbush. The firm currently has a $72.00 price target on the stock.

Great Portland Estates (LON:GPE) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 351 target price on the stock.

Grainger (LON:GRI) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a GBX 200 price target on the stock.

Hammerson (LON:HMSO) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 351 target price on the stock.

ImmunityBio (NASDAQ:IBRX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $15.00 price target on the stock.

Keller Group (LON:KLR) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 3,450 target price on the stock.

CarMax (NYSE:KMX) was upgraded by analysts at Bank of America Corporation from an underperform rating to a buy rating. Bank of America Corporation currently has $65.00 target price on the stock.

Krystal Biotech (NASDAQ:KRYS) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $361.00 target price on the stock.

Lithium Americas (NYSE:LAC) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a speculative buy rating.

Land Securities Group (LON:LAND) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a GBX 593 target price on the stock.

Living Reit (LON:LIVE) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 80 price target on the stock.

LondonMetric Property (LON:LMP) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 217 target price on the stock.

Mondi (LON:MNDI) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 1,080 price target on the stock.

Morgan Stanley (NYSE:MS) had its outperform rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $230.00 target price on the stock, down from their previous target price of $250.00.

ArcelorMittal (NYSE:MT) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.

NewRiver REIT (LON:NRR) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 87 price target on the stock.

Norcros (LON:NXR) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Norcros (LON:NXR) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 440 target price on the stock.

Pegasystems (NASDAQ:PEGA) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $47.00 price target on the stock.

Primary Health Properties (LON:PHP) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 107 target price on the stock.

Praxis Precision Medicines (NASDAQ:PRAX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $1,201.00 target price on the stock.

ProCook Group (LON:PROC) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 62 price target on the stock.

Porvair (LON:PRV) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 1,050 target price on the stock.

Portillo’s (NASDAQ:PTLO) had its equal weight rating reissued by analysts at Stephens. Stephens currently has a $5.00 target price on the stock.

Rio Tinto Group (LON:RIO) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 8,700 target price on the stock.

Rocket Lab (NASDAQ:RKLB) had its buy rating reiterated by analysts at TD Cowen. The firm currently has a $90.00 target price on the stock.

Rocket Lab (NASDAQ:RKLB) had its mixed rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $122.00 target price on the stock.

Revolution Medicines (NASDAQ:RVMD) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $275.00 target price on the stock.

Robert Walters (LON:RWA) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 160 price target on the stock.

RXO (NYSE:RXO) was downgraded by analysts at Citizens Jmp from an outperform rating to a market perform rating.

Shaftesbury Capital (LON:SHC) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 170 price target on the stock.

Siemens (OTCMKTS:SIEGY) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating.

Standard Chartered (LON:STAN) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 3,040 target price on the stock.

Sutro Biopharma (NASDAQ:STRO) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $60.00 price target on the stock.

Supermarket Income REIT (LON:SUPR) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 90 price target on the stock.

Tatton Asset Management (LON:TAM) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 820 target price on the stock.

THG (LON:THG) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 60 target price on the stock.

Target Healthcare REIT (LON:THRL) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 124 target price on the stock.

Tesla (NASDAQ:TSLA) had its sell rating reissued by analysts at Glj Research.

Texas Roadhouse (NASDAQ:TXRH) was upgraded by analysts at Stephens from an equal weight rating to an overweight rating. The firm currently has $205.00 target price on the stock.

UnitedHealth Group (NYSE:UNH) had its hold rating reaffirmed by analysts at TD Cowen. The firm currently has a $402.00 price target on the stock.

Workspace Group (LON:WKP) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 367 price target on the stock.

XPS Pensions Group (LON:XPS) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 469 target price on the stock.

YouGov (LON:YOU) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 460 price target on the stock.

Zions Bancorporation, N.A. (NASDAQ:ZION) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. Robert W. Baird currently has $75.00 price target on the stock.